[
    {
        "drugresponse_id": "47770",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A673",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0080",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47772",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47774",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "8.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47776",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "5637",
        "VALUE": "9.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0126",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47779",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TCCSUP",
        "VALUE": "8.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1738",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47780",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47781",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "C-4-I",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2253",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47782",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ME-180",
        "VALUE": "8.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1401",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47784",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47785",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A172",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0131",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47786",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "GB-1",
        "VALUE": "9.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1227",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47790",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "YKG-1",
        "VALUE": "8.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1796",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47791",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ChaGo-K-1",
        "VALUE": "8.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1121",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Bronchogenic Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47793",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Calu-3",
        "VALUE": "8.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0609",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47794",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "COR-L23",
        "VALUE": "8.91",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1139",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47795",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LK-2",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1377",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47796",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1437",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1472",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47798",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1648",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1482",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47799",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1650",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1483",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Bronchiolo-Alveolar Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47801",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1770",
        "VALUE": "9.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1493",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47803",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2085",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1523",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47804",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2170",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1535",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47805",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2228",
        "VALUE": "9.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1543",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47806",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2342",
        "VALUE": "9.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1549",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47808",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2405",
        "VALUE": "8.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1551",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47811",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "DMS-273",
        "VALUE": "8.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1176",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47812",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1048",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1453",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47816",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1963",
        "VALUE": "8.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1510",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47820",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2171",
        "VALUE": "8.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1536",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47824",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H526",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1569",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47825",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H64",
        "VALUE": "8.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1573",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47829",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47831",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47833",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SBC-5",
        "VALUE": "8.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1679",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47835",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LU-135",
        "VALUE": "9.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1389",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47836",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-N-SH",
        "VALUE": "8.63",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0531",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47837",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2030",
        "VALUE": "9.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1517",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47838",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2122",
        "VALUE": "9.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1531",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47840",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H650",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1575",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47843",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1299",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0060",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47844",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2087",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1524",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47845",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "UM-UC-3",
        "VALUE": "8.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1783",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47847",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H727",
        "VALUE": "8.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1584",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Carcinoid Tumor",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47848",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Calu-6",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0236",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47850",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1355",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1464",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47851",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1792",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1495",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47853",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MIA-PaCa-2",
        "VALUE": "8.91",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0428",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Ductal Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47854",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SHP-77",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1693",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47855",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2009",
        "VALUE": "9.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1514",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47858",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TE-5",
        "VALUE": "8.55",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1764",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47859",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC1954",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1259",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47862",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC1599",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1256",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47864",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC2157",
        "VALUE": "8.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1261",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47866",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC38",
        "VALUE": "8.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1267",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47867",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BB30-HNC",
        "VALUE": "9.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1076",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Head and Neck Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47869",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BB65-RCC",
        "VALUE": "9.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1078",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47871",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BHY",
        "VALUE": "9.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1086",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Head and Neck Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47872",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Ca9-22",
        "VALUE": "9.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1102",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Gingival Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47873",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CAL-12T",
        "VALUE": "9.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1105",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47874",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CAL-33",
        "VALUE": "8.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1108",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Tongue Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47878",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CTV-1",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1150",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47882",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EBC-1",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2891",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47884",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EPLC-272H",
        "VALUE": "8.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1197",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Mucoepidermoid Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47885",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HA7-RCC",
        "VALUE": "9.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1241",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47886",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47887",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HO-1-u-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2784",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Oral Cavity Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47888",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HSC-2",
        "VALUE": "9.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1287",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Oral Cavity Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47890",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "IST-SL1",
        "VALUE": "8.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1313",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47891",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "IST-SL2",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1314",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47892",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "J82",
        "VALUE": "8.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0359",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47893",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KOSC-2",
        "VALUE": "9.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1337",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Head and Neck Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47894",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KP-4",
        "VALUE": "9.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1338",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47895",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KYSE-140",
        "VALUE": "8.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1347",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47896",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KYSE-410",
        "VALUE": "8.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1352",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47898",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KYSE-70",
        "VALUE": "8.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1356",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47899",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LB1047-RCC",
        "VALUE": "8.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1364",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47900",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LB2241-RCC",
        "VALUE": "8.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1365",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47903",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LB647-SCLC",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1368",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47904",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LB771-HNC",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1369",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Head and Neck Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47905",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LB831-BLC",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1370",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47906",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LB996-RCC",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1371",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47907",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LCLC-103H",
        "VALUE": "9.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1375",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47910",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LXF-289",
        "VALUE": "9.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1394",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47911",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MS-1",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1429",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47912",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MZ1-PC",
        "VALUE": "9.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1434",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Ductal Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47913",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "8.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47916",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H292",
        "VALUE": "8.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0455",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Mucoepidermoid Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47918",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "PC-14",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1640",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47919",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SBC-3",
        "VALUE": "8.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1678",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47921",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TE-15",
        "VALUE": "9.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1763",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47922",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "U-266",
        "VALUE": "8.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0566",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Plasma Cell Myeloma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47924",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47926",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TE-1",
        "VALUE": "8.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1759",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47927",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TE-10",
        "VALUE": "9.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1760",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47928",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TE-8",
        "VALUE": "9.7",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1766",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47929",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CAPAN-1",
        "VALUE": "8.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0237",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Ductal Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47930",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OVCAR-3",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0465",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "High Grade Ovarian Serous Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47932",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "DU-145",
        "VALUE": "9.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0105",
        "ONCOTREE_LINEAGE": "Prostate",
        "ONCOTREE_PRIMARY_DISEASE": "Prostate Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47933",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCT-116",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0291",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47934",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCT-15",
        "VALUE": "9.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0292",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47935",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HL-60",
        "VALUE": "8.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0002",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47936",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HT-29",
        "VALUE": "9.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0320",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47937",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "K-562",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0004",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47940",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H460",
        "VALUE": "9.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0459",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47941",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H522",
        "VALUE": "9.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1567",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47943",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MCF7",
        "VALUE": "9.45",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0031",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47944",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "786-0",
        "VALUE": "9.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1051",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47946",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A549",
        "VALUE": "8.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0023",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47947",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ACHN",
        "VALUE": "8.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1067",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Papillary Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47948",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BT-549",
        "VALUE": "8.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1092",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47949",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CCRF-CEM",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0207",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47951",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "8.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47954",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MOLT-4",
        "VALUE": "8.55",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0013",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47955",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-OV-3",
        "VALUE": "8.45",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0532",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Serous Cystadenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47957",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "COLO-205",
        "VALUE": "9.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0218",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47958",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SW620",
        "VALUE": "9.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0547",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47959",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CAKI-1",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0234",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Clear Cell Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47960",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "RPMI-8226",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0014",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Plasma Cell Myeloma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47961",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SR",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1711",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Large Cell Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47963",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "IGROV-1",
        "VALUE": "9.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1304",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Endometrioid Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47964",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OVCAR-5",
        "VALUE": "8.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1628",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "High Grade Ovarian Serous Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47966",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC2998",
        "VALUE": "9.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1266",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47967",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HOP-62",
        "VALUE": "8.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1285",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47973",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "RXF393",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1673",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47974",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SN12C",
        "VALUE": "8.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1705",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47975",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TK10",
        "VALUE": "8.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1773",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Clear Cell Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47976",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "U031",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1911",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47977",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SNB75",
        "VALUE": "8.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1706",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47979",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "8.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47980",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SF295",
        "VALUE": "8.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1690",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47981",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47982",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KM12",
        "VALUE": "8.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1331",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47983",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OVCAR-4",
        "VALUE": "8.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1627",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "High Grade Ovarian Serous Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47984",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OVCAR-8",
        "VALUE": "8.91",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1629",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "High Grade Ovarian Serous Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47985",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BxPC-3",
        "VALUE": "8.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0186",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Ductal Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47986",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BHT-101",
        "VALUE": "8.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1085",
        "ONCOTREE_LINEAGE": "Thyroid",
        "ONCOTREE_PRIMARY_DISEASE": "Thyroid Gland Anaplastic Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47987",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47988",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BE-13",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1081",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47989",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ARH-77",
        "VALUE": "8.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1072",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Cancerous",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47990",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "AGS",
        "VALUE": "8.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0139",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Gastric Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47991",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ABC-1",
        "VALUE": "8.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1066",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47992",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A2058",
        "VALUE": "9.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1059",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47993",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A375",
        "VALUE": "9.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0132",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47995",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "8305C",
        "VALUE": "8.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1053",
        "ONCOTREE_LINEAGE": "Thyroid",
        "ONCOTREE_PRIMARY_DISEASE": "Thyroid Gland Anaplastic Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47996",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "647-V",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1049",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47997",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "639-V",
        "VALUE": "9.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1048",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47998",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "697",
        "VALUE": "8.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0079",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47999",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BT-20",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0178",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48000",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A2780",
        "VALUE": "8.93",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0134",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Endometrioid Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48001",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "COR-L105",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1138",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48006",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "COLO-680N",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1131",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48007",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "COLO-679",
        "VALUE": "8.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1130",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48008",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CHP-212",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1125",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48009",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CFPAC-1",
        "VALUE": "8.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1119",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Ductal Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48010",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Ca-Ski",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1100",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48014",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CAL-62",
        "VALUE": "9.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1112",
        "ONCOTREE_LINEAGE": "Thyroid",
        "ONCOTREE_PRIMARY_DISEASE": "Thyroid Gland Anaplastic Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48017",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "DB",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1168",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Diffuse Large B-Cell Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48018",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Daoy",
        "VALUE": "9.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1167",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48020",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "DBTRG-05MG",
        "VALUE": "8.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1169",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48021",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "DEL",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1170",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Large Cell Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48022",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Detroit562",
        "VALUE": "8.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1171",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Pharyngeal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48025",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48026",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "DOHH-2",
        "VALUE": "8.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1179",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Diffuse Large B-Cell Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48027",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "DoTc2-4510",
        "VALUE": "8.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1181",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48028",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "DU-4475",
        "VALUE": "8.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1183",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48029",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EB2",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1186",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Epstein-Barr Virus-Related Burkitt s Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48031",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ECC10",
        "VALUE": "8.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1188",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Gastric Small Cell Neuroendocrine Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48032",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EFM-19",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0253",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48033",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EFO-27",
        "VALUE": "8.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1192",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Mucinous Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48036",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EoL-1-cell",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0258",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Eosinophilic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48037",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ETK-1",
        "VALUE": "8.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1206",
        "ONCOTREE_LINEAGE": "Biliary Tract",
        "ONCOTREE_PRIMARY_DISEASE": "Intrahepatic Cholangiocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48041",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "G-361",
        "VALUE": "8.91",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1220",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48042",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "GAMG",
        "VALUE": "8.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1226",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48043",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "GCIY",
        "VALUE": "8.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1228",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Gastric Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48044",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "GDM-1",
        "VALUE": "8.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1230",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48045",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48046",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "8.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48048",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "GR-ST",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1236",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48049",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "GCT",
        "VALUE": "8.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1229",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Undifferentiated Pleomorphic Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48050",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ESS-1",
        "VALUE": "8.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1205",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Stromal Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48051",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "H4",
        "VALUE": "9.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1239",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48052",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "H9",
        "VALUE": "8.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1240",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Mycosis Fungoides and Sezary Syndrome",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48053",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HC-1",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1243",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Hairy Cell Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48055",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC1569",
        "VALUE": "8.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1255",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48056",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC1806",
        "VALUE": "8.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1258",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Breast Carcinoma Acantholytic Variant",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48057",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC70",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1270",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48058",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HEC-1",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1274",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48059",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HEL",
        "VALUE": "8.45",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0001",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Erythroleukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48060",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HGC-27",
        "VALUE": "9.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1279",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Gastric Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48061",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HH",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1280",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48062",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HLE",
        "VALUE": "9.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1281",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48063",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HMV-II",
        "VALUE": "8.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1282",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48064",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HOS",
        "VALUE": "9.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0312",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48065",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HSC-3",
        "VALUE": "9.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1288",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Tongue Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48068",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HT-1080",
        "VALUE": "8.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0317",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Fibrosarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48071",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "8.7",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48073",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HuCCT1",
        "VALUE": "8.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0324",
        "ONCOTREE_LINEAGE": "Biliary Tract",
        "ONCOTREE_PRIMARY_DISEASE": "Intrahepatic Cholangiocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48074",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HuH-7",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0336",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48076",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HuTu-80",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1301",
        "ONCOTREE_LINEAGE": "Small Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Duodenal Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48077",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "IGR-1",
        "VALUE": "9.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1303",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48078",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48079",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "IPC-298",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1307",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Cutaneous Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48080",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48083",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "JEG-3",
        "VALUE": "8.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0363",
        "ONCOTREE_LINEAGE": "Placenta",
        "ONCOTREE_PRIMARY_DISEASE": "Gestational Choriocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48084",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "JiyoyeP-2003",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1317",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Epstein-Barr Virus-Related Burkitt s Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48087",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48088",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KARPAS-45",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1326",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48091",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KE-37",
        "VALUE": "8.7",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1327",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48092",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KG-1",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0374",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48095",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KMS-12-BM",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1334",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Plasma Cell Myeloma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48096",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48097",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HuP-T3",
        "VALUE": "8.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1299",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48098",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HuP-T4",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1300",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48102",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "GP5d",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1235",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48104",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "G-402",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1221",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Cell Type Gastrointestinal Stromal Tumor",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48105",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "G-401",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0270",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Rhabdoid Tumour of the Kidney",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48107",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KU812",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0379",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48109",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KS-1",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1343",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48111",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KYSE-150",
        "VALUE": "9.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1348",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48112",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KYSE-180",
        "VALUE": "9.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1349",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48113",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KYSE-270",
        "VALUE": "9.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1350",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48114",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KYSE-450",
        "VALUE": "9.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1353",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48115",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KYSE-510",
        "VALUE": "9.89",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1354",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48119",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LC-2-ad",
        "VALUE": "9.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1373",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48121",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LNCaP-Clone-FGC",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1379",
        "ONCOTREE_LINEAGE": "Prostate",
        "ONCOTREE_PRIMARY_DISEASE": "Prostate Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48122",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LOUCY",
        "VALUE": "8.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1380",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48123",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LoVo",
        "VALUE": "8.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0399",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48125",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LS-123",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1383",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48126",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LS-411N",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1385",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Cecum Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48128",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LU-99A",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1393",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Giant Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48129",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MC116",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1399",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "B-Cell Non-Hodgkin's Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48130",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MC-IXC",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1398",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Askin's Tumor",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48134",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MDA-MB-468",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0419",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48135",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MEL-HO",
        "VALUE": "8.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1402",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48136",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MEL-JUSO",
        "VALUE": "8.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1403",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Cutaneous Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48137",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MEG-01",
        "VALUE": "8.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0425",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48138",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MES-SA",
        "VALUE": "8.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1404",
        "ONCOTREE_LINEAGE": "Uterus",
        "ONCOTREE_PRIMARY_DISEASE": "Uterine Corpus Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48141",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MFE-296",
        "VALUE": "8.45",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1406",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48142",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MHH-ES-1",
        "VALUE": "9.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1411",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48143",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "8.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48144",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MHH-PREB-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1413",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "B-Cell Non-Hodgkin's Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48145",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MKN1",
        "VALUE": "8.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1415",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Gastric Adenosquamous Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48146",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MKN28",
        "VALUE": "9.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1416",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Gastric Tubular Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48147",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ML-2",
        "VALUE": "8.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1418",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48150",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MOG-G-CCM",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2613",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48151",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MOG-G-UVW",
        "VALUE": "8.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2614",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48152",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MOLT-16",
        "VALUE": "8.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1424",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48155",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MPP-89",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1427",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Pleural Epithelioid Mesothelioma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48156",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MRK-nu-1",
        "VALUE": "9.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1428",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48158",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MV-4-11",
        "VALUE": "8.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0064",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood Acute Differentiated Monocytic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48159",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NALM-6",
        "VALUE": "8.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0092",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48160",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NAMALWA",
        "VALUE": "8.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0067",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Epstein-Barr Virus-Related Burkitt s Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48161",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48162",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCCIT",
        "VALUE": "8.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1451",
        "ONCOTREE_LINEAGE": "Testis",
        "ONCOTREE_PRIMARY_DISEASE": "Testicular Embryonal Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48163",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H520",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1566",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48167",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "8.93",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48168",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NKM-1",
        "VALUE": "8.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1607",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48169",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "8.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48171",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NOMO-1",
        "VALUE": "8.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1609",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult Acute Monocytic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48172",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48173",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NTERA-2-cl-D1",
        "VALUE": "9.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3407",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48174",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NUGC-3",
        "VALUE": "8.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1612",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Gastric Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48175",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H747",
        "VALUE": "8.63",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1587",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Cecum Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48178",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H441",
        "VALUE": "8.55",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1561",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Papillary Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48182",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H358",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1559",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Bronchiolo-Alveolar Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48189",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1703",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1490",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48196",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48198",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OS-RC-2",
        "VALUE": "8.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1626",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48199",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "P12-ICHIKAWA",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1630",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48200",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "P30-OHK",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1631",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48202",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "PA-1",
        "VALUE": "9.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0479",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Mixed Germ Cell Tumor",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48203",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48204",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OC-314",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1616",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Serous Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48205",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "PF-382",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1641",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48208",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "RD",
        "VALUE": "8.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1649",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Embryonal Rhabdomyosarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48209",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "REH",
        "VALUE": "8.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1650",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48210",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "RF-48",
        "VALUE": "8.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1657",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48211",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "RKO",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0504",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48213",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "RPMI-6666",
        "VALUE": "8.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1665",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Cancerous",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48214",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "RPMI-8402",
        "VALUE": "8.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1667",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48215",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "RS4-11",
        "VALUE": "8.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0093",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48216",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "RT-112",
        "VALUE": "9.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1670",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48221",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SF126",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1688",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48222",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48223",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SIG-M5",
        "VALUE": "9.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1694",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48225",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "8.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48226",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-HEP-1",
        "VALUE": "8.89",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0525",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48227",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "9.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48228",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-LU-1",
        "VALUE": "8.55",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0629",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48232",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-MEL-30",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0039",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Cutaneous Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48233",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-MES-1",
        "VALUE": "8.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0630",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48234",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-MG-1",
        "VALUE": "8.93",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1698",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48235",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48236",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-UT-1",
        "VALUE": "9.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0533",
        "ONCOTREE_LINEAGE": "Uterus",
        "ONCOTREE_PRIMARY_DISEASE": "Uterine Corpus Leiomyosarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48237",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SNG-M",
        "VALUE": "9.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1707",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48238",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SNU-387",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0250",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48239",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SNU-423",
        "VALUE": "8.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0366",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48240",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SNU-449",
        "VALUE": "8.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0454",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48242",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SNU-C2B",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1710",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Cecum Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48245",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SW13",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0542",
        "ONCOTREE_LINEAGE": "Adrenal Gland",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Cortex Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48246",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SW1088",
        "VALUE": "8.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1715",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48249",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SW1710",
        "VALUE": "10.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1721",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48250",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SW1783",
        "VALUE": "8.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1722",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48251",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SW48",
        "VALUE": "8.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1724",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48252",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SW626",
        "VALUE": "8.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1725",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48255",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SW872",
        "VALUE": "9.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1730",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Liposarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48257",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SW962",
        "VALUE": "8.93",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1733",
        "ONCOTREE_LINEAGE": "Vulva",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48258",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SW982",
        "VALUE": "9.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1734",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Synovial Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48259",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "T84",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0555",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48261",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TGBC11TKB",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1768",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Gastric Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48263",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TUR",
        "VALUE": "8.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1775",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult Acute Monocytic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48265",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "U-698-M",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0017",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Precursor Lymphoblastic Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48268",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "VMRC-RCZ",
        "VALUE": "9.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1791",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48270",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "WSU-NHL",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1793",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Follicular Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48275",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KURAMOCHI",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1345",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "High Grade Ovarian Serous Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48276",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KM-H2",
        "VALUE": "8.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1330",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Hodgkin's Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48278",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OE19",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1622",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48280",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Ramos-2G6-4C10",
        "VALUE": "8.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1646",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Burkitt's Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48282",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "QIMR-WIL",
        "VALUE": "8.89",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1645",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48283",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "PSN1",
        "VALUE": "9.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1644",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48284",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OAW-42",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1615",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Serous Cystadenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48285",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OE33",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0471",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Barrett s Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48288",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CGTH-W-1",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1120",
        "ONCOTREE_LINEAGE": "Thyroid",
        "ONCOTREE_PRIMARY_DISEASE": "Thyroid Gland Anaplastic Carcinoma Squamous Cell Carcinoma Pattern",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48289",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "COLO-320-HSR",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0220",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48290",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ATN-1",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1073",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48291",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CESS",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0209",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48293",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "COLO-684",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1132",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48296",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TGBC24TKB",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1770",
        "ONCOTREE_LINEAGE": "Biliary Tract",
        "ONCOTREE_PRIMARY_DISEASE": "Gallbladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48297",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.93",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48298",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BFTC-909",
        "VALUE": "8.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1084",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Pelvis Urothelial Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48300",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SCC-25",
        "VALUE": "8.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1682",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Tongue Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48303",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "AU565",
        "VALUE": "8.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1074",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48304",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BALL-1",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1075",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48305",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BL-41",
        "VALUE": "8.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1087",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Burkitt's Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48306",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BV-173",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0181",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48307",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "IA-LM",
        "VALUE": "9.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1302",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48309",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "AN3-CA",
        "VALUE": "9.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0028",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Endometrial Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48310",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A204",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1058",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Embryonal Rhabdomyosarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48311",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NY",
        "VALUE": "8.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1613",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48312",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "C3A",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1098",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatoblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48313",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A427",
        "VALUE": "9.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1055",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48314",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CAL-85-1",
        "VALUE": "9.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1114",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48315",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CHL-1",
        "VALUE": "9.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1122",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48317",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1651",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1484",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48318",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "RPMI-7951",
        "VALUE": "8.93",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1666",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48319",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SCC-4",
        "VALUE": "8.96",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1684",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Tongue Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48321",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ST486",
        "VALUE": "8.96",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1712",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Burkitt's Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48324",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SCC-15",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1681",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Tongue Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48326",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CAL-27",
        "VALUE": "9.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1107",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Tongue Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48327",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BC-3",
        "VALUE": "8.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1080",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Primary Effusion Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48328",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BC-1",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1079",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Primary Effusion Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48329",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A704",
        "VALUE": "8.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1065",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48330",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "9.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48331",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "769-P",
        "VALUE": "9.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1050",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Clear Cell Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48332",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "23132-87",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1046",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Gastric Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48333",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A431",
        "VALUE": "9.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0037",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48334",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BFTC-905",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1083",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48335",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CAL-51",
        "VALUE": "8.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1110",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48338",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48339",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48340",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A4-Fuk",
        "VALUE": "8.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1064",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48341",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A3-KAW",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1062",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Diffuse Large B-Cell Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48343",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NEC8",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1604",
        "ONCOTREE_LINEAGE": "Testis",
        "ONCOTREE_PRIMARY_DISEASE": "Testicular Embryonal Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48345",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ALL-PO",
        "VALUE": "8.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1069",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48346",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OCI-AML2",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1619",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48350",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LS-1034",
        "VALUE": "8.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1382",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Cecum Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48351",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "22RV1",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1045",
        "ONCOTREE_LINEAGE": "Prostate",
        "ONCOTREE_PRIMARY_DISEASE": "Prostate Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48352",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "8505C",
        "VALUE": "9.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1054",
        "ONCOTREE_LINEAGE": "Thyroid",
        "ONCOTREE_PRIMARY_DISEASE": "Thyroid Gland Anaplastic Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48353",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "B-CPAP",
        "VALUE": "9.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0153",
        "ONCOTREE_LINEAGE": "Thyroid",
        "ONCOTREE_PRIMARY_DISEASE": "Papillary Thyroid Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48354",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BPH-1",
        "VALUE": "9.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1091",
        "ONCOTREE_LINEAGE": "Prostate",
        "ONCOTREE_PRIMARY_DISEASE": "Benign Prostatic Hyperplasia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48355",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CAL-148",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1106",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48356",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CAL-39",
        "VALUE": "9.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1109",
        "ONCOTREE_LINEAGE": "Vulva",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48359",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HO-1-N-1",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1284",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Oral Cavity Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48360",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HTC-C3",
        "VALUE": "8.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1295",
        "ONCOTREE_LINEAGE": "Thyroid",
        "ONCOTREE_PRIMARY_DISEASE": "Thyroid Gland Anaplastic Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48361",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KGN",
        "VALUE": "9.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0375",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Granulosa Cell Tumor",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48364",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "K5",
        "VALUE": "8.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1322",
        "ONCOTREE_LINEAGE": "Thyroid",
        "ONCOTREE_PRIMARY_DISEASE": "Follicular Thyroid Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48365",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "L-363",
        "VALUE": "8.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1357",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Plasma Cell Myeloma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48367",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1975",
        "VALUE": "8.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1511",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48368",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SW954",
        "VALUE": "9.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1732",
        "ONCOTREE_LINEAGE": "Vulva",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48373",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MKN45",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0434",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Gastric Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48374",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H810",
        "VALUE": "9.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1590",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48375",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MFH-ino",
        "VALUE": "9.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1407",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Undifferentiated Pleomorphic Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48376",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NOS-1",
        "VALUE": "8.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1610",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48377",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "PANC-03-27",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1635",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48379",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "PANC-10-05",
        "VALUE": "8.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1639",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Ductal Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48385",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TE-9",
        "VALUE": "8.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1767",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48386",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TE-11",
        "VALUE": "8.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1761",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48388",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TE-12",
        "VALUE": "8.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1762",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48391",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OAW-28",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1614",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "High Grade Ovarian Serous Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48392",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LCLC-97TM1",
        "VALUE": "9.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1376",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48393",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "8.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48396",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "D-423MG",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1160",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48398",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "D-566MG",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1166",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48403",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "M059J",
        "VALUE": "8.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0400",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48404",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HAL-01",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1242",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48406",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48407",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "9.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48408",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48409",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "9.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48410",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EW-7",
        "VALUE": "8.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1217",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48412",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48413",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48414",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48415",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "8.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48418",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "8.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48421",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48423",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NB13",
        "VALUE": "9.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1443",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48424",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "8.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48426",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "RH-1",
        "VALUE": "9.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_C355",
        "ONCOTREE_LINEAGE": "",
        "ONCOTREE_PRIMARY_DISEASE": "",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48427",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48428",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LS-180",
        "VALUE": "9.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0397",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48430",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BICR78",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2315",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Oral Cavity Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48431",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CCK-81",
        "VALUE": "8.63",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2873",
        "ONCOTREE_LINEAGE": "Large Intestine",
        "ONCOTREE_PRIMARY_DISEASE": "Colon Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48438",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2595",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_A545",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Pleural Epithelioid Mesothelioma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48441",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2804",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_U998",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Malignant Pleural Mesothelioma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48443",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H290",
        "VALUE": "8.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_A555",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Malignant Pleural Mesothelioma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48444",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H3118",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_A464",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Parotid Gland Mucoepidermoid Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48446",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HARA",
        "VALUE": "8.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2914",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48447",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC-15",
        "VALUE": "8.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2057",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48448",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC-44",
        "VALUE": "9.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2060",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48450",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Hep3B2-1-7",
        "VALUE": "8.62",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0326",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48451",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Hs-633T",
        "VALUE": "9.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0832",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48452",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Hs-683",
        "VALUE": "8.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0844",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Oligodendroglioma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48453",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "IGR-37",
        "VALUE": "8.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2075",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48454",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "IHH-4",
        "VALUE": "9.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2960",
        "ONCOTREE_LINEAGE": "Thyroid",
        "ONCOTREE_PRIMARY_DISEASE": "Papillary Thyroid Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48455",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "IM-95",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2961",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Gastric Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48457",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "JHH-4",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2787",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48458",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "JHH-6",
        "VALUE": "8.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2788",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48459",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "JHH-7",
        "VALUE": "9.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2805",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48460",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "JHU-011",
        "VALUE": "9.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_5986",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Laryngeal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48462",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48463",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KYSE-220",
        "VALUE": "8.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1359",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48464",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LN-18",
        "VALUE": "8.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0392",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48465",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LN-229",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0393",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48469",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MFE-319",
        "VALUE": "9.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2112",
        "ONCOTREE_LINEAGE": "Endometrium",
        "ONCOTREE_PRIMARY_DISEASE": "Adenosquamous Endometrial Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48470",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ML-1",
        "VALUE": "8.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_H525",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48471",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MS751",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_4996",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48472",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "8.55",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48475",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1915",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1505",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48476",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1944",
        "VALUE": "8.62",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1508",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48478",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H211",
        "VALUE": "8.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1529",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48479",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H3122",
        "VALUE": "8.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_5160",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48480",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H647",
        "VALUE": "8.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1574",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Adenosquamous Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48482",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H847",
        "VALUE": "9.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1596",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48483",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OSC-20",
        "VALUE": "8.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3087",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Oral Cavity Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48487",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OVMIU",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3112",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "High Grade Ovarian Serous Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48488",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "PA-TU-8988T",
        "VALUE": "8.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1847",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48489",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "PC-3_[JPC-3]",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_S982",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48490",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "PCI-15A",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_C184",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Pyriform Fossa Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48491",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "PCI-38",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_M471",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Head and Neck Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48492",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "PCI-6A",
        "VALUE": "9.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_C173",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Head and Neck Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48496",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SISO",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2193",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48497",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SKN",
        "VALUE": "8.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3167",
        "ONCOTREE_LINEAGE": "Uterus",
        "ONCOTREE_PRIMARY_DISEASE": "Uterine Corpus Leiomyosarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48498",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SNU-398",
        "VALUE": "9.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0077",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48499",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SU8686",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3881",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48500",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SUIT-2",
        "VALUE": "8.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3172",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Ductal Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48504",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TT2609-C02",
        "VALUE": "9.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2218",
        "ONCOTREE_LINEAGE": "Thyroid",
        "ONCOTREE_PRIMARY_DISEASE": "Follicular Thyroid Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48505",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "VMRC-RCW",
        "VALUE": "9.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1790",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48507",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SUP-B15",
        "VALUE": "8.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0103",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48508",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "H3255",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_6831",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48509",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "451Lu",
        "VALUE": "8.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_6357",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48510",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OCI-AML3",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1844",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48511",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ASH-3",
        "VALUE": "8.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2856",
        "ONCOTREE_LINEAGE": "Thyroid",
        "ONCOTREE_PRIMARY_DISEASE": "Thyroid Gland Anaplastic Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48513",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BICR31",
        "VALUE": "8.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2312",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Tongue Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48514",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CAL-29",
        "VALUE": "8.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1808",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48519",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CS1",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_T023",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48521",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EFM-192A",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1812",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48524",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2369",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_A532",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Malignant Pleural Mesothelioma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48533",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ALL-SIL",
        "VALUE": "8.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1805",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48534",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "AMO-1",
        "VALUE": "8.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1806",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Plasma Cell Myeloma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48538",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Farage",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3302",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Diffuse Large B-Cell Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48539",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HeLa",
        "VALUE": "9.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0030",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48540",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HPAC",
        "VALUE": "8.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3517",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48543",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Hs-940-T",
        "VALUE": "8.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1038",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48545",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "JHH-1",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2785",
        "ONCOTREE_LINEAGE": "Liver",
        "ONCOTREE_PRIMARY_DISEASE": "Hepatocellular Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48546",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "JHU-029",
        "VALUE": "8.89",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_5993",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Laryngeal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48547",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "JIMT-1",
        "VALUE": "9.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2077",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48549",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KMH-2",
        "VALUE": "8.93",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_S641",
        "ONCOTREE_LINEAGE": "Thyroid",
        "ONCOTREE_PRIMARY_DISEASE": "Thyroid Gland Anaplastic Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48552",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KON",
        "VALUE": "9.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3001",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Oral Cavity Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48553",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KP-1N",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3002",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Ductal Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48554",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KP-2",
        "VALUE": "9.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3004",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48555",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KP-3",
        "VALUE": "8.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3005",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Adenosquamous Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48556",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KYSE-50",
        "VALUE": "9.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1360",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48560",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1568",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1476",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48563",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2110",
        "VALUE": "8.63",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1530",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48567",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NUGC-4",
        "VALUE": "8.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3082",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Signet Ring Cell Gastric Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48569",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OE21",
        "VALUE": "8.45",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2661",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48570",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OSC-19",
        "VALUE": "9.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3086",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Tongue Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48571",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OVTOKO",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3117",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Clear Cell Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48576",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "PCI-4B",
        "VALUE": "9.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_C171",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Laryngeal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48578",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "RERF-LC-KJ",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1654",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48582",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SCC90",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1899",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Head and Neck Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48584",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "STS-0421",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_X508",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Gastric Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48585",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SW1271",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1716",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48586",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "T-T",
        "VALUE": "9.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3174",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48587",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TMK-1",
        "VALUE": "8.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_4384",
        "ONCOTREE_LINEAGE": "Stomach",
        "ONCOTREE_PRIMARY_DISEASE": "Gastric Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48588",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TOV-112D",
        "VALUE": "9.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3612",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Endometrioid Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48589",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "VCaP",
        "VALUE": "8.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2235",
        "ONCOTREE_LINEAGE": "Prostate",
        "ONCOTREE_PRIMARY_DISEASE": "Prostate Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48590",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "WM1552C",
        "VALUE": "8.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_6472",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48591",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "WM35",
        "VALUE": "8.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0580",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48592",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "WM793B",
        "VALUE": "8.93",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_8787",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48597",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Hs-445",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0761",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Cancerous",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48599",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NB4",
        "VALUE": "8.96",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0005",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Acute Promyelocytic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48600",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "JJN-3",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2078",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Plasma Cell Myeloma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48601",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "JM1",
        "VALUE": "8.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3532",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48602",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "JSC-1",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3728",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Primary Effusion Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48604",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KARPAS-231",
        "VALUE": "8.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1822",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48605",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KARPAS-620",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1823",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Plasma Cell Myeloma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48606",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KCL-22",
        "VALUE": "8.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2091",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48607",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KOPN-8",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1866",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Childhood B Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48611",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MOLM-13",
        "VALUE": "8.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2119",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48612",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MOLP-8",
        "VALUE": "8.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2124",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Plasma Cell Myeloma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48613",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MY-M12",
        "VALUE": "8.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3035",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Acute Biphenotypic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48615",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NK-92MI",
        "VALUE": "8.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3755",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Natural Killer Cell Lymphoblastic Leukemia or Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48616",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NU-DUL-1",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1877",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Diffuse Large B-Cell Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48617",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OCI-AML5",
        "VALUE": "8.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1620",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48618",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OCI-LY-19",
        "VALUE": "8.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1878",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Diffuse Large B-Cell Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48619",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "OCI-M1",
        "VALUE": "8.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2149",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48620",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "P32-ISH",
        "VALUE": "8.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3119",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Burkitt's Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48621",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "PL-21",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2161",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Acute Myeloid Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48624",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SC-1",
        "VALUE": "8.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1888",
        "ONCOTREE_LINEAGE": "Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48625",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SLVL",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3169",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Splenic Marginal Zone B-Cell Lymphoma with Villous Lymphocytes",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48626",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SU-DHL-16",
        "VALUE": "8.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1890",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "B-Cell Non-Hodgkin's Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48628",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SU-DHL-5",
        "VALUE": "9.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1735",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Diffuse Large B-Cell Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48629",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SU-DHL-6",
        "VALUE": "8.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2206",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Diffuse Large B-Cell Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48630",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SU-DHL-8",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2207",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Diffuse Large B-Cell Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48632",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SUP-M2",
        "VALUE": "8.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2209",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Large Cell Lymphoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48633",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TK",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3216",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Chronic Myelogenous Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "48635",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "WIL2-NS",
        "VALUE": "8.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2761",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Hereditary Spherocytosis",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47770",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A673",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0080",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47772",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47774",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "8.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47776",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "5637",
        "VALUE": "9.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0126",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47779",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TCCSUP",
        "VALUE": "8.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1738",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47780",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "C-33-A",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1094",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47781",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "C-4-I",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2253",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47782",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ME-180",
        "VALUE": "8.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1401",
        "ONCOTREE_LINEAGE": "Cervix",
        "ONCOTREE_PRIMARY_DISEASE": "Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47784",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47785",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "A172",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0131",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47786",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "GB-1",
        "VALUE": "9.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1227",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47790",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "YKG-1",
        "VALUE": "8.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1796",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47791",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "ChaGo-K-1",
        "VALUE": "8.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1121",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Bronchogenic Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47793",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Calu-3",
        "VALUE": "8.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0609",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47794",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "COR-L23",
        "VALUE": "8.91",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1139",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47795",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LK-2",
        "VALUE": "8.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1377",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47796",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1437",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1472",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47798",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1648",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1482",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47799",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1650",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1483",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Bronchiolo-Alveolar Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47801",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1770",
        "VALUE": "9.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1493",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47803",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2085",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1523",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47804",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2170",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1535",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47805",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2228",
        "VALUE": "9.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1543",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47806",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2342",
        "VALUE": "9.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1549",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47808",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2405",
        "VALUE": "8.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1551",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47811",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "DMS-273",
        "VALUE": "8.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1176",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47812",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1048",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1453",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47816",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1963",
        "VALUE": "8.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1510",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47820",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2171",
        "VALUE": "8.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1536",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47824",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H526",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1569",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47825",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H64",
        "VALUE": "8.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1573",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47829",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47831",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47833",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SBC-5",
        "VALUE": "8.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1679",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47835",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "LU-135",
        "VALUE": "9.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1389",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47836",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SK-N-SH",
        "VALUE": "8.63",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0531",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47837",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2030",
        "VALUE": "9.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1517",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47838",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2122",
        "VALUE": "9.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1531",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47840",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H650",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1575",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47843",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1299",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0060",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47844",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2087",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1524",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47845",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "UM-UC-3",
        "VALUE": "8.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1783",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47847",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H727",
        "VALUE": "8.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1584",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Carcinoid Tumor",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47848",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Calu-6",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0236",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47850",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1355",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1464",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47851",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H1792",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1495",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47853",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "MIA-PaCa-2",
        "VALUE": "8.91",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0428",
        "ONCOTREE_LINEAGE": "Pancreas",
        "ONCOTREE_PRIMARY_DISEASE": "Pancreatic Ductal Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47854",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "SHP-77",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1693",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47855",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "NCI-H2009",
        "VALUE": "9.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1514",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47858",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "TE-5",
        "VALUE": "8.55",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1764",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47859",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC1954",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1259",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47862",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC1599",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1256",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47864",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC2157",
        "VALUE": "8.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1261",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47866",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCC38",
        "VALUE": "8.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1267",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47867",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BB30-HNC",
        "VALUE": "9.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1076",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Head and Neck Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47869",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BB65-RCC",
        "VALUE": "9.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1078",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47871",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "BHY",
        "VALUE": "9.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1086",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Head and Neck Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47872",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "Ca9-22",
        "VALUE": "9.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1102",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Gingival Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47873",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CAL-12T",
        "VALUE": "9.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1105",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47874",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CAL-33",
        "VALUE": "8.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1108",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Tongue Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47878",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "CTV-1",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1150",
        "ONCOTREE_LINEAGE": "Haematopoietic and Lymphoid",
        "ONCOTREE_PRIMARY_DISEASE": "Adult T Acute Lymphoblastic Leukemia",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47882",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EBC-1",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2891",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47884",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "EPLC-272H",
        "VALUE": "8.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1197",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Mucoepidermoid Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47885",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HA7-RCC",
        "VALUE": "9.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1241",
        "ONCOTREE_LINEAGE": "Kidney",
        "ONCOTREE_PRIMARY_DISEASE": "Renal Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47886",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47887",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HO-1-u-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2784",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Oral Cavity Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47888",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "HSC-2",
        "VALUE": "9.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1287",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Oral Cavity Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47890",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "IST-SL1",
        "VALUE": "8.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1313",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47891",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "IST-SL2",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1314",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47892",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "J82",
        "VALUE": "8.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0359",
        "ONCOTREE_LINEAGE": "Bladder",
        "ONCOTREE_PRIMARY_DISEASE": "Bladder Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    },
    {
        "drugresponse_id": "47893",
        "COMPOUND_NAME": "Epothilone B",
        "CELL_LINE_NAME": "KOSC-2",
        "VALUE": "9.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "448013.0",
        "CHEMBL_ID": "CHEMBL94657",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1337",
        "ONCOTREE_LINEAGE": "Head and Neck",
        "ONCOTREE_PRIMARY_DISEASE": "Head and Neck Squamous Cell Carcinoma",
        "INCHI_KEY": "QXRSDHAAWVKZLJ-PVYNADRNSA-N",
        "COMPOUND_CLASS": "Nuclear_receptor inhibitors",
        "Disease_class": "Congenital and neonatal",
        "Disease_name": "Dysplastic Nevus Syndrome",
        "Phase": "2"
    }
]